%0 Journal Article %T Challenges of urine-based molecular assays for the detection of urothelial cancer %A de Jong, Joep J. %A van Kessel, Kim E. M. %A Roobol, Monique J. %A Boormans, Joost L. %J Translational Andrology and Urology %D 2019 %B 2019 %9 %! Challenges of urine-based molecular assays for the detection of urothelial cancer %K %X In the issue of Modern Pathology , April 25 2019, Eich and colleagues highlight the relevance of a urine assay called ‘UroSEEK’ as a non-invasive approach for the detection of primary or recurrent urothelial carcinoma of the bladder (UCB). The UROSEEK assay consists of three components; TERTSeqS, UroSeqS, and FastSeqS, which cover molecular alterations in 11 genes that frequently occur in UCB, in addition to aneuploidy (FastSeqS) (1). %U https://tau.amegroups.org/article/view/28820 %P S493-S496 %@ 2223-4691